ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,155,885 | -53.5% | 4,360,807 | -16.6% | 0.00% | -66.7% |
Q2 2023 | $49,803,866 | +25.3% | 5,226,009 | +44.6% | 0.00% | +50.0% |
Q1 2023 | $39,762,591 | -63.5% | 3,614,781 | -50.9% | 0.00% | -33.3% |
Q4 2022 | $108,909,796 | +114.6% | 7,358,770 | +177.1% | 0.00% | 0.0% |
Q3 2022 | $50,742,000 | +70.5% | 2,655,235 | +90.1% | 0.00% | +50.0% |
Q2 2022 | $29,758,000 | +29.9% | 1,396,425 | +17.4% | 0.00% | +100.0% |
Q1 2022 | $22,910,000 | -1.4% | 1,189,500 | +6.2% | 0.00% | 0.0% |
Q4 2021 | $23,235,000 | -6.4% | 1,120,306 | +7.8% | 0.00% | 0.0% |
Q3 2021 | $24,827,000 | -21.1% | 1,039,213 | -9.8% | 0.00% | -50.0% |
Q2 2021 | $31,451,000 | +12.3% | 1,152,482 | +19.1% | 0.00% | 0.0% |
Q1 2021 | $28,004,000 | +18.7% | 967,982 | +15.4% | 0.00% | +100.0% |
Q4 2020 | $23,602,000 | +203.5% | 839,022 | +216.1% | 0.00% | 0.0% |
Q3 2020 | $7,777,000 | +37.8% | 265,434 | +42.3% | 0.00% | – |
Q2 2020 | $5,642,000 | +13.0% | 186,580 | +11.4% | 0.00% | – |
Q1 2020 | $4,993,000 | – | 167,558 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
Two Seas Capital LP | 164,807 | $875,125 | 0.18% |